Efficacy of the selective prostaglandin synthase type 2 inhibitor nimesulide in blocking basal prostaglandin production and delaying glucocorticoid-induced premature labor in sheep

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 5, 1999, Pages 1244-1253

  Poore, Kirsten R ^b   Young, I Ross ^b   Hirst, Jonathan J ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Labor; Nimesulide; Prostaglandin; Prostaglandin endoperoxidase H synthase; Sheep

Indexed keywords

6 METHOXY 2 NAPHTHYLACETIC ACID; GLUCOCORTICOID; NIMESULIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INHIBITION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS INHIBITION; SHEEP;

EID: 0032996024     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70624-1     Document Type: Article

References (28)

1. 1. Olson D, Zakar T, Mitchell B. Prostaglandin synthesis regulation by intrauterine tissues. In: Rice G, Brennecke S, editors. Molecular aspects of placental and fetal membrane autacoids. Boca Raton (FL): CRC Press; 1993. p. 55-95.
2. 2. Rice GE, Wong MH, Thorburn GD. Gestational changes in prostaglandin synthase activity of ovine cotyledonary microsomes. J Endocrinol 1988;118:265-70.
3. 3. Teixeira FJ, Zakar T, Hirst JJ, Guo F, Sadowsky DW, Machin G, et al. Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. J Clin Enocrinol Metab 1994;78:139-402
4. 4. McLaren WJ, Young IR, Wong MH, Rice GE. Expression of prostaglandin G/H synthase-1 and -2 in ovine amnion and placenta following glucocorticoid-induced labour onset. J Endocrinol 1996;151:125-35.
5. 5. Mitchell M, Flint A. Use of meclofenamic acid to investigate the role of prostaglandin biosynthesis during induced parturition in sheep. J Endocrinol 1978;76:101-9.
6. 6. Novy MJ, Cook MJ, Manaugh L. Indomethacin block of normal onset of parturition in primates. Am J Obstet Gynecol 1974;118:412-6.
7. 7. Van den Veyver IB, Moise KJ Jr. Prostaglandin synthetase inhibitors in pregnancy. Obstet Gynecol Surv 1993;48:493-502.
8. 8. Levin D, Mills L, Parkey M, Garriott J, Campbell W. Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe. J Pediatr 1979;94:647-50.
9. 9. Xie W, Mertill JR, Bradshaw WS, Simmons DL. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 1993;300:247-52.
10. 10. Wen PZ, Warden G, Fletcher BS, Kujubu DA, Herschman HR, Lusis AJ. Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse. Genomics 1993;15:458-60.
11. 11. Smith W, Meade E, DeWitt D. Interactions of PGH synthase isozymes-1 and-2 with NSAIDs. Ann NY Acad Sci 1994;744:50-7.
12. 12. Hirst JJ, Teixeira FJ, Zakar T, Olsoo DM. Prostaglandin endoperoxide-H synthase-1 and-2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. J Clin Endocrinol Metab 1995;80:517-23.
13. 13. Rice GE, Freed KA, Aitken MA, Jacobs RA. Gestational-and labour-associated changes in the relative abundance of prostaglandin G/H synthase-1 and-2 mRNA in ovine placenta. J Mol Endocrinol 1995;14:237-45.
14. 14. Liggins G, Thorbum G. Initiation of parturition. In: Lamming G, editor. Marshall's physiology of reproduction. Norwell (MA): Chapman & Hall; 1994. p. 866-1015.
15. 15. Coceani F, Olley PM. The control of cardiovascular shunts in the fetal and perinatal period. Can J Phys Pharmacol 1988;66:1129-34.
16. 16. Pace-Asciak CR, Rangaraj G. The 6-ketoprostaglandin FIalpha pathway in the lamb ductus arteriosus. Biochim Biophys Acta 1977;486:583-5.
17. 17. Coceani F, Olley PM, Bodach E. Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2. Prostaglandins 1975;9:299-308.
18. 18. Tavares IA, Bishai PM, Bennett A. Activity of nimesulide on constitutive and inducible cyclooxygenase. Arzneimittelforschung 1995;45:1093-5.
19. 19. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-4.
20. 20. Magni E. The effect of nimesulide on prostanoid formation. Drugs 1993;46:10-4.
21. 21. Melarange R, Gentry C, O'Connell C, Blower P, Neil C, Kelvin A, et al. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin. Agents Actions 1992;Suppl:C82-3.
22. 22. Bernareggi A. The pharmacokinetic profile of nimesulide in healthy volunteers. Drugs 1993;46(suppl 1):64-72.
23. 23. Soma L, Uboh C, Rudy J, Smith M. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses. Am J Vet Res 1996;57:517-21.
24. 24. Sawdy R, Slater D, Fisk N, Edmonds D, Bennett P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997;350: 265-6.
25. 25. Fowden AL, Harding R, Ralph MM, Thorburn GD. The nutritional regulation of plasma prostaglandin E concentrations in the fetus and pregnant ewe during late gestation. J Physiol 1987;394:1-12.
26. 26. Burgess KM, Ralph MM, Jenkin G, Thorburn GD. Effect of oxytocin and estradiol on uterine prostaglandin release in non-pregnant and early-pregnant ewes. Biol Reprod 1990;42:822-33.
27. 27. MacDonald PC, Casey ML. The accumulation of prostaglandins (PG) in amniotic fluid is an aftereffect of labor and not indicative of a role for PGE2 or PGF2 alpha in the initiation of human parturition. J Clin Endocrinol Metab 1993;76:1332-9.
28. 28. Riendeau D, Charleson S, Cromlish W, Mancini J, Wong E, Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997;75:1008-95.